Collaborative plasma biomarkers for Parkinson's disease development and progression: a cross-sectional and longitudinal study.

Yang JiaoXue ZhuXinyi ZhouYuanyuan LiLiche ZhouAonan ZhaoNingdi LuoMengyue Niu Liche Zhou

Published in: European journal of neurology (2023)

Our study suggested that the combined measurement of plasma CCL2, CXCL12, and neuronal exosomal α-syn can improve early-stage PD diagnosis, and CCL2 may serve as a prognostic marker for PD progression.

Keyphrases

early stage
liver fibrosis
liver injury
drug induced
quality improvement
squamous cell carcinoma
lymph node